252270089	252270089	CD	B-NP	O
|	|	NN	I-NP	O
MGOAH	MGOAH	NN	I-NP	O
|	|	NN	I-NP	O
46416177	46416177	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3381534	3381534	CD	B-NP	O
|	|	CC	I-NP	O
11/10/2006	11/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2006	11/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/19/2006	2/19/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MCLATCHY	MCLATCHY	NNP	B-NP	O
,	,	,	O	O
CHRIS	CHRIS	NNP	B-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Allaway	Allaway	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
52-year-old	52-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Dutchesscanscot	Dutchesscanscot	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	I-NP	O
myalgias	myalgia	NNS	I-NP	O
and	and	CC	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
11	11	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-VP	O
donated	donate	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
takes	take	VBZ	B-VP	O
cyclosporine	cyclosporine	NN	B-NP	O
and	and	CC	I-NP	O
azathioprine	azathioprine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
neuropathic	neuropathic	JJ	I-NP	O
left	left	JJ	I-NP	O
plantar	plantar	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
seven	seven	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
transmetatarsal	transmetatarsal	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
at	at	IN	B-PP	O
Reus	Reus	NNP	B-NP	O
Ortston	Ortston	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
recurrent	recurrent	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
years	year	NNS	I-NP	O
or	or	CC	I-NP	O
so	so	RB	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
nonetheless	nonetheless	RB	B-ADVP	O
was	be	VBD	B-VP	O
reasonably	reasonably	RB	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
and	and	CC	I-ADVP	O
very	very	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
35-mile	35-mile	JJ	I-NP	O
bike	bike	NN	I-NP	O
ride	ride	NN	I-NP	O
in	in	IN	B-PP	O
about	about	RB	B-NP	O
four	four	CD	I-NP	O
or	or	CC	I-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
developed	develop	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
weakness	weakness	NN	B-NP	O
and	and	CC	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tried	try	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
found	find	VBD	B-VP	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
adequate	adequate	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
weak	weak	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Copot	Copot	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Centers	Center	NNPS	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
moderate	moderate	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
and	and	CC	I-NP	O
dehydration	dehydration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
workup	workup	NN	I-NP	O
also	also	RB	B-ADVP	O
suggested	suggest	VBD	B-VP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
dyskinesis	dyskinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
apical	apical	JJ	I-NP	O
walls	wall	NNS	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Transesophageal	Transesophageal	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
intact	intact	JJ	B-NP	O
interatrial	interatrial	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrium	atrium	NN	B-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
thrombus	thrombus	NN	B-NP	O
,	,	,	O	O
inferobasilar	inferobasilar	JJ	B-NP	O
and	and	CC	I-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
old	old	JJ	B-NP	O
inferoposterior	inferoposterior	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
trileaflet	trileaflet	VB	B-VP	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
mobile	mobile	JJ	I-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
significant	significant	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
pulmonic	pulmonic	JJ	I-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
aortic	aortic	JJ	B-NP	O
atherosclerosis	atherosclerosis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
which	which	WDT	B-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Streptococcus	Streptococcus	NNP	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
and	and	CC	I-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
foot	foot	NN	I-NP	O
became	become	VBD	B-VP	O
clearly	clearly	RB	B-ADJP	O
boggy	boggy	JJ	I-ADJP	O
and	and	CC	O	O
grossly	grossly	RB	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
necrosis	necrosis	NN	B-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
of	of	IN	B-PP	O
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
guillotine	guillotine	NN	B-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
normalized	normalize	VBD	B-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
foot	foot	NN	I-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Bacteroides	Bacteroide	NNS	B-NP	O
fragilis	fragilis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
received	receive	VBD	B-VP	I-protein
ampicillin	ampicillin	NN	B-NP	I-protein
and	and	CC	I-NP	O
sulbactam	sulbactam	NN	I-NP	O
for	for	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
on	on	IN	B-PP	O
11/2/06	11/2/06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
main	main	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ostial	ostial	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Formal	Formal	JJ	B-NP	O
report	report	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Johni	Johni	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
II	II	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
transmetatarsal	transmetatarsal	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
left	left	JJ	I-NP	O
guillotine	guillotine	NN	I-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
foot	foot	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
11	11	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	IN	B-PP	O
TRANSFER	TRANSFER	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
cyclosporine	cyclosporine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
azathioprine	azathioprine	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
74	74	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
72	72	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
6	6	CD	I-NP	O
feet	foot	NNS	I-NP	O
2	2	CD	B-NP	O
inches	inch	NNS	I-NP	O
tall	tall	JJ	B-ADJP	O
,	,	,	O	O
113.63	113.63	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
98.6	98.6	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
79	79	CD	B-NP	O
and	and	CC	I-NP	O
regular	regular	JJ	I-NP	O
,	,	,	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
right	right	JJ	I-NP	O
arm	arm	NN	I-NP	O
130/65	130/65	CD	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
arm	arm	NN	B-NP	O
137/68	137/68	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	B-protein
vascular	vascular	JJ	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Carotid	Carotid	NNP	B-NP	O
,	,	,	O	O
radial	radial	JJ	B-NP	O
and	and	CC	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
nonpalpable	nonpalpable	JJ	B-NP	O
left	left	JJ	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
dopplerable	dopplerable	JJ	B-NP	O
right	right	JJ	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
135	135	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
113	113	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
10.6	10.6	CD	I-NP	I-cell_line
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
29.9	29.9	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
501	501	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
PT-INR	PT-INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Kincer	Kincer	NNP	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
2/1/06	2/1/06	CD	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
x4	x4	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sequential	sequential	JJ	I-NP	O
graft	graft	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
from	from	IN	B-PP	O
aorta	aorta	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ramus	ramus	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
internal	internal	JJ	B-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	RB	B-ADVP	O
descending	descend	VBG	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
121	121	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
crossclamp	crossclamp	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
104	104	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
intraoperatively	intraoperatively	RB	I-ADVP	O
,	,	,	O	O
came	come	VBD	B-VP	O
off	off	RP	B-PRT	O
bypass	bypass	NN	B-NP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Step-Down	Step-Down	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
Service	Service	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
recommended	recommend	VBN	B-VP	O
treating	treat	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
total	total	NN	B-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
left	left	JJ	I-NP	I-DNA
leg	leg	NN	I-NP	I-DNA
BKA	BKA	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
tubes	tube	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
post-pull	post-pull	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Chang	Chang	NNP	I-NP	O
Eichberger	Eichberger	NNP	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
revision	revision	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
BKA	BKA	NN	I-NP	O
on	on	IN	B-PP	O
11/9/06	11/9/06	CD	B-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Strathman	Strathman	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Mellitus	Mellitus	NNP	I-NP	O
Service	Service	NNP	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
experienced	experience	VBD	B-VP	O
some	some	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
failed	failed	JJ	I-NP	O
voiding	void	VBG	I-NP	O
trials	trial	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
leg	leg	NN	I-NP	O
bag	bag	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
urologist	urologist	NN	I-NP	O
within	within	IN	B-PP	O
five	five	CD	B-NP	O
to	to	TO	I-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
assigned	assign	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
already	already	RB	I-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
worked	work	VBD	B-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
pivot	pivot	VB	I-VP	O
with	with	IN	B-PP	O
assist	assist	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Farrelly	Farrelly	NNP	I-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
visiting	visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Berne	Berne	NNP	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
postoperative	postoperative	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
23.4	23.4	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
required	require	VBD	B-VP	O
further	further	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hemodiluted	hemodilute	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
on	on	IN	B-PP	O
sternal	sternal	JJ	B-NP	O
precautions	precaution	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
BKA	BKA	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
sternal	sternal	JJ	B-NP	O
precautions	precaution	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
134	134	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.6	4.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
136	136	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
8.30	8.30	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
23.4	23.4	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
7.5	7.5	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
471	471	CD	B-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	B-cell_line
16.7	16.7	CD	I-NP	I-cell_line
,	,	,	O	O
PT/INR	PT/INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.3	1.3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
37.1	37.1	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Vitamin	Vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
azathioprine	azathioprine	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
cyclosporine	cyclosporine	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Sandimmune	Sandimmune	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
doses	dose	NNS	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
t.i.d.	t.i.d.	RB	B-ADVP	O
subcutaneously	subcutaneously	RB	I-ADVP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
8	8	CD	B-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
4-6	4-6	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
100	100	CD	I-NP	O
units	unit	NNS	I-NP	O
q.	q.	RB	B-NP	O
8	8	CD	I-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
remaining	remain	VBG	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Villot	Villot	NNP	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jordon	Jordon	NNP	I-NP	O
Chuck	Chuck	NNP	I-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Carey	Carey	NNP	I-NP	O
Buhlig	Buhlig	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
urologist	urologist	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
signed	sign	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
within	within	IN	B-PP	O
five	five	CD	B-NP	O
to	to	TO	I-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
Dr.	Dr.	NNP	B-NP	O
Mauricio	Mauricio	NNP	I-NP	O
Ovalle	Ovalle	NNP	I-NP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
visiting	visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
immobilizer	immobilizer	NN	I-NP	O
brace	brace	NN	I-NP	O
on	on	IN	B-PP	O
until	until	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Cienfuegos	Cienfuegos	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-3020162	6-3020162	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
AYMOND	AYMOND	NNP	B-NP	O
,	,	,	O	O
DORIAN	DORIAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SAVITSKY	SAVITSKY	NNP	B-NP	O
,	,	,	O	O
CURT	CURT	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1483458	1483458	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/15/06	7/15/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/6/06	11/6/06	CD	B-NP	O

